Hemispherx Announces Dutch Health Inspectorate Approval to Extend the Ampligen Pancreatic Cancer Early Access Program Until March 2020

February 28, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search